Rotigotine transdermal patch in Parkinson's disease: a systematic review and meta-analysis. - Wikidata - wikimedia - TriplyDB

Rotigotine transdermal patch in Parkinson's disease: a systematic review and meta-analysis.

Rotigotine transdermal patch in Parkinson's disease: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34921068

about

Behavioral and neurophysiological effects of transdermal rotigotine in atypical parkinsonism.Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy.Novel levodopa formulations in the treatment of Parkinson's disease.Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease.Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.

P2860

Q33713621-D9C14D17-EDF8-4AB6-AFB7-81D6C1BECFC0 Q33734770-5272F270-D18D-4BA4-AF50-CDA29ECEFF0B Q38178754-C209DEF9-70D3-4A8D-BC5B-B3C4A9215B59 Q38223072-D1C5E813-6C64-4283-B87A-3D018530BEAE Q41455787-0BD1F803-6829-4E38-A364-CBD3528F90FC Q48051574-73FC8A86-06E3-4848-A498-817A2EA8F21E

P2860

Rotigotine transdermal patch in Parkinson's disease: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34921068

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@ast

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@en

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@nl

type

label

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@ast

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@en

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@nl

prefLabel

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@ast

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@en

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@nl

P1433

Q34921068-9A982C17-E5D8-48DA-A86A-7701D1FDCF20

P1476

Q34921068-01F3CDA8-F85F-4896-98CF-206B6957F7A3

P2093

Q34921068-00870E6F-168B-4CFA-AB9E-86BF8E40F8B9

Q34921068-105D16C6-1C18-4D02-8F2F-0C3095537473

Q34921068-3D6827E2-5E3A-42B7-8ED7-22A181E5A3BD

Q34921068-4129C209-51C0-443C-BE79-198F3BBEDD6B

Q34921068-A2B36D9F-15D6-4DF0-BCB0-CEEAA3F74526

Q34921068-E3779996-5264-4FF0-B9ED-C5B1A3C6D2D5

P275

Q34921068-9132F17B-D30F-4BC8-983F-4B623F9E616B

P2860

Q34921068-11FB93D3-A2F8-45F3-AC7B-30FB22645279

Q34921068-2A0CB719-D49B-49BE-8980-0136F655B9C8

Q34921068-2E15C65D-9CD5-4F26-AC45-724765F94A99

Q34921068-39AF1A62-957F-4FE9-BE08-F039E776DB0F

Q34921068-46804FED-74BC-4531-A223-9B490F04A96D

Q34921068-4799B533-C1D4-42A7-AFDB-CE0388C23023

Q34921068-49A0E8A1-26A8-42EA-8BF9-4FDA25242481

Q34921068-6072FB11-FA56-4243-A817-4238FEC4AF1B

Q34921068-7E51B77F-E795-47BF-BAD7-10BDAD1E8950

Q34921068-8640EE84-0D26-44B2-A7E4-37E601B982B7

P304

Q34921068-B2F3B695-193B-4CF9-B144-3E0849AD6652

P31

Q34921068-5193254A-56B7-4481-911D-87F7B52027F3

Q34921068-93CD9438-4DB5-48EA-90B5-A35D2E2AD2BA

Q34921068-c439e3a4-6191-40a3-b0c6-5f18d78716f6

P356

Q34921068-C43B3733-1CAE-4757-9459-E25367E0F66A

P407

Q34921068-64C53C58-D19F-48F7-B679-4A9F701759AC

P433

Q34921068-36EA0F79-D2CA-4BCC-9DA7-620E9F3D60D8

P478

Q34921068-A6F0B626-9FFC-45B8-9986-7E3B178B5BAC

P5008

Q34921068-16D28616-0EA6-4783-9665-5C41D02ADE43

P577

Q34921068-BF8C94FD-283D-4F69-BF27-5222130587E6

P5875

Q34921068-580F028D-C7BF-4A49-AB87-C056A1F5A9DE

P698

Q34921068-E78D5E2F-E5C0-4CC3-8051-0D29AE495FBA

P921

Q34921068-9E8AEB01-CDA5-4BE5-AA7D-7ABECA5B6428

Q34921068-A24DB729-30AB-4DC9-9AEB-45083B19E47A

Q34921068-C7C1E4CB-63A0-41B6-8819-5E93EE14EF7C

Q34921068-FE497687-A8EB-42AD-82FA-535FF4340865

P932

Q34921068-247EDF7B-8960-4C2F-8137-23355D419F79

P356

JOURNAL.PONE.0069738

P1433

P1476

Rotigotine transdermal patch i ...... atic review and meta-analysis.

@en

P2093

Chang-Qing Zhou

http://www.w3.org/2001/XMLSchema#string

Feng-Qun Li

http://www.w3.org/2001/XMLSchema#string

Guo-Guang Peng

http://www.w3.org/2001/XMLSchema#string

Peng Lei

http://www.w3.org/2001/XMLSchema#string

Shan-Shan Li

http://www.w3.org/2001/XMLSchema#string

Zhong-Mei Chen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

A controlled trial of rotigotine monotherapy in early Parkinson's disease

Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials

Transdermal rotigotine for the perioperative management of Parkinson's disease.

Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai.

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).

Levodopa in the treatment of Parkinson's disease: current controversies.

A novel dopamine agonist for the transdermal treatment of Parkinson's disease.

P304

e69738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0069738

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255737337

http://www.w3.org/2001/XMLSchema#string

P698

23936090

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

heterocyclic compound

polycyclic compound

P932

3720658

http://www.w3.org/2001/XMLSchema#string